CID 16161422

Schembl29403197

Structural Information

Molecular Formula
C83H97N27O40P6
SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COCC3=CC(=C(C=C3)OCC4=CC=CC=C4)OCC5=CC=CC=C5)OP(=O)(O)OC[C@@H]6[C@H](C[C@@H](O6)N7C=NC8=C7N=C(NC8=O)N)OP(=O)(O)OC[C@@H]9[C@H](C[C@@H](O9)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OC[C@@H]1[C@H](C[C@@H](O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCCO
InChI
InChI=1S/C83H97N27O40P6/c1-39-23-105(83(117)104-74(39)112)57-17-45(51(139-57)27-130-24-42-12-13-43(131-25-40-8-4-2-5-9-40)44(16-42)132-26-41-10-6-3-7-11-41)146-152(120,121)134-30-54-48(20-60(142-54)108-36-93-65-71(108)97-80(86)101-76(65)114)149-155(126,127)137-32-56-50(22-62(144-56)110-38-95-67-73(110)99-82(88)103-78(67)116)150-156(128,129)138-31-55-49(21-61(143-55)109-37-94-66-72(109)98-81(87)102-77(66)115)148-154(124,125)136-29-53-47(18-58(140-53)106-34-91-63-68(84)89-33-90-69(63)106)147-153(122,123)135-28-52-46(145-151(118,119)133-15-14-111)19-59(141-52)107-35-92-64-70(107)96-79(85)100-75(64)113/h2-13,16,23,33-38,45-62,111H,14-15,17-22,24-32H2,1H3,(H,118,119)(H,120,121)(H,122,123)(H,124,125)(H,126,127)(H,128,129)(H2,84,89,90)(H,104,112,117)(H3,85,96,100,113)(H3,86,97,101,114)(H3,87,98,102,115)(H3,88,99,103,116)/t45-,46-,47-,48-,49-,50-,51+,52+,53+,54+,55+,56+,57+,58+,59+,60+,61+,62+/m0/s1
InChIKey
YRRFHZVLPDRUHE-DBBFKXDPSA-N
Compound name
[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[(2R,3S,5R)-2-[[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[(2R,3S,5R)-2-[[3,4-bis(phenylmethoxy)phenyl]methoxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl] 2-hydroxyethyl hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

4
References

35
Patents

2297.4812 Da
Monoisotopic Mass

-9.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2298.4885 238.7
[M+Na]+ 2320.4704 249.1
[M-H]- 2296.4739 239.1
[M+NH4]+ 2315.5150 242.3
[M+K]+ 2336.4444 245.5
[M+H-H2O]+ 2280.4785 237.3
[M+HCOO]- 2342.4794 243.3
[M+CH3COO]- 2356.4951 245.0
[M+Na-2H]- 2318.4559 248.4
[M]+ 2297.4807 247.1
[M]- 2297.4817 247.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe